EVOTEC INTERNATIONAL GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 17238
 
 
 
C07D HETEROCYCLIC COMPOUNDS 16146
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 445
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
 
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
 
 
C07K PEPTIDES 1135
 
 
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 121

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9708274 Sulfoximine substituted quinazolines for pharmaceutical compositionsJul 17, 15Jul 18, 17[A61K, C07D]
9139577 Sulfoximine substituted quinazolines for pharmaceutical compositionsJun 26, 14Sep 22, 15[A61K, C07D]
9049849 Screening methods for compounds useful for treating pancreatic dysfunctionFeb 18, 11Jun 09, 15[A61K, A01K, C40B, C07K]
9029323 Neurturin conjugates for pharmaceutical useMay 05, 10May 12, 15[A61K, C07K]
8901138 Sulfoximine substituted quinazolines for pharmaceutical compositionsNov 07, 13Dec 02, 14[A61K, C07D, A61P]
8853193 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositionsFeb 25, 11Oct 07, 14[A61K, C07D, A61P]
8772233 Method for promoting regeneration of pancreatic beta-cells by administering neurturinFeb 15, 13Jul 08, 14[A61K]
8754079 Cycloalkyl containing thienopyrimidines for pharmaceutical compositionsFeb 25, 11Jun 17, 14[A61K, C07D, A61P]
8697713 Pyrrolopyrimidines for pharmaceutical compositionsJul 10, 07Apr 15, 14[A61K, A01N, C07D]
8648068 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositionsFeb 25, 11Feb 11, 14[A61K, C07D, A61P]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0274,897 METHOD FOR PREVENTING AND TREATING DIABETES USING NEURTURINAbandonedMay 27, 14Sep 18, 14[A61K]
2014/0213,510 USE OF PLEITROPHIN FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROMEAbandonedFeb 22, 13Jul 31, 14[C07K]
2014/0162,948 FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURINAbandonedSep 26, 13Jun 12, 14[A61K]
2013/0231,283 NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USEAbandonedFeb 01, 13Sep 05, 13[C07K]
8501473 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndromeExpiredJul 15, 04Aug 06, 13[C12N]
8399408 Method for treating diabetes using neurturinExpiredFeb 15, 11Mar 19, 13[A61K, A61P]
2013/0053,313 NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURINAbandonedAug 27, 12Feb 28, 13[A61K, A61P]
7968535 Use of azapaullones for preventing and treating pancreatic autoimmune disordersExpiredMay 04, 06Jun 28, 11[A61K, C07D]
2011/0053,951 METHODS FOR TREATING DISORDERS USING NMDA NR2B-SUBTYPE SELECTIVE ANTAGONISTAbandonedMar 26, 09Mar 03, 11[A61K, A61P]
2010/0234,359 TREATMENT OF SLEEP DISORDERSAbandonedAug 19, 08Sep 16, 10[A61K, A61P]
2009/0298,771 USE OF SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROMEAbandonedMay 08, 09Dec 03, 09[A61K, C12Q, G01N]
7211563 Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasisExpiredMar 28, 02May 01, 07[A61K]
7005432 Substituted imidazol-pyridazine derivativesExpiredMay 09, 03Feb 28, 06[A61K]
6605723 Process for the preparation of ethanesul fonyl-piperidine derivativesExpiredMar 15, 01Aug 12, 03[C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.